Helix has since shut down its app store and stopped selling genome sequencing directly to consumers.
Notes on verification
Corroborated by multiple independent trade press sources (GenomeWeb, FierceBiotech, Becker's), industry analysts (CB Insights, Crunchbase), and a competitor review site, all consistent on timeline and pivot to B2B/population genomics.
Sources
- Why some 'breakthrough' technologies don't work out (technologyreview.com)
- https://sequencing.com/blog/post/dna-app-store (sequencing.com)
- https://www.fiercebiotech.com/medtech/dna-sequencing-test-maker-helix-doubles-down-covid-19-testing-tracking-50m-series-c (fiercebiotech.com)
- https://www.cbinsights.com/research/helix-genomics-business-model/ (cbinsights.com)
- https://www.genomeweb.com/business-news/helix-reduces-workforce-closes-offices-amid-strategic-shift (genomeweb.com)
- https://nebula.org/blog/helix-dna-review/ (nebula.org)
- https://www.cbinsights.com/company/helix (cbinsights.com)